PERIOD ENDING | 15-Feb-04 | 23-Nov-03 | 31-Aug-03 | 11-May-03 | Total Revenue | 11,548,974 | 10,521,478 | 13,689,729 | 9,543,071 | Cost of Revenue | 10,101,977 | 9,220,122 | 11,987,752 | 8,358,323 | | Gross Profit | 1,446,997 | 1,301,356 | 1,701,977 | 1,184,748 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,084,605 | 1,032,413 | 1,318,259 | 923,309 | | Non Recurring | 7,216 | 14,125 | 9,528 | 11,853 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | Operating Income or Loss | 355,176 | 254,818 | 374,190 | 249,586 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,072 | 7,903 | 12,729 | 9,179 | | Earnings Before Interest And Taxes | 368,248 | 262,721 | 386,919 | 258,765 | | Interest Expense | 8,261 | 8,475 | 11,734 | 8,715 | | Income Before Tax | 359,987 | 254,246 | 375,185 | 250,050 | | Income Tax Expense | 133,195 | 94,071 | 135,759 | 96,270 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 226,792 | 160,175 | 239,426 | 153,780 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | Net Income | 226,792 | 160,175 | 239,426 | 153,780 | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | Net Income Applicable To Common Shares | $226,792 | $160,175 | $239,426 | $153,780 |
|